Analysed IMMUNEERING CORP - CLASS A (IMRX:NASDAQ) News Sources
Immuneering Reports First Quarter 2026 Financial Results and Provides Business Updates
15-05-2026
yahoo.com
Immuneering Reports 17.3 Months Median Overall Survival in First-Line Metastatic Pancreatic Cancer Patients Treated with Atebimetinib Plus Chemotherapy
21-05-2026
yahoo.com
Immuneering Presents Compelling 17.3-Month Median Overall Survival and Favorable Tolerability with Atebimetinib + Chemotherapy in First-Line Pancreatic Cancer Patients at ASCO
01-06-2026
yahoo.com
IMRX Stock On Track For Worst Day In Nearly 5 Months — What’s Driving The Selloff?
01-06-2026
stocktwits.com
Immuneering Announces First Patient Dosed in Pivotal Phase 3 MAPKeeper 301 Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer
11-06-2026
yahoo.com
What is the current price of IMMUNEERING CORP - CLASS A (IMRX:NASDAQ)?
The current price of IMMUNEERING CORP - CLASS A (IMRX:NASDAQ) is $4.64.
IMMUNEERING CORP - CLASS A (IMRX:NASDAQ) absolute price change since previous trading day?
The absolute price change of IMMUNEERING CORP - CLASS A (IMRX:NASDAQ) since the previous trading day is $-0.14.
IMMUNEERING CORP - CLASS A (IMRX:NASDAQ) percentage price change since previous trading day?
The percentage price change of IMMUNEERING CORP - CLASS A (IMRX:NASDAQ) since the previous trading day is -2.9289%.
What is the most recent average sentiment score for IMMUNEERING CORP - CLASS A (IMRX:NASDAQ)?
The most recent average sentiment score for IMMUNEERING CORP - CLASS A (IMRX:NASDAQ) is 69 out of 100.
What is the most recent average sentiment for IMMUNEERING CORP - CLASS A (IMRX:NASDAQ)?
The most recent sentiment for IMMUNEERING CORP - CLASS A (IMRX:NASDAQ) is .
SEC-8K** Filing Available For IMMUNEERING CORP - CLASS A (IMRX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.